GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
In accordance with DTR 3.1.4 R(1)(c) GlaxoSmithKline plc ('GSK') was advised on 10 June 2016 of the following increase in the notional allocation of GSK American Depositary Shares ('ADSs') on 9 June 2016, at a price of $42.06 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401(K) plan:
Connected Person |
Number of ADSs |
Dr K Slaoui (Connected Person of Dr M M Slaoui) |
1 |
V A Whyte
Company Secretary
10 June 2016